Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horton Valve is a medical device company focused on the development of next-generation transcatheter heart valve technologies. The company's primary mission is to provide minimally invasive solutions for patients suffering from mitral and tricuspid valve regurgitation, conditions that often require complex surgical intervention. Their proprietary valve design is engineered to adapt to the challenging anatomy of the heart's atrioventricular valves, aiming to improve hemodynamic performance and patient safety. Based in the medical technology hub of Irvine, California, Horton Valve is positioned within the structural heart sector to address significant unmet clinical needs. The company is currently advancing its technology through the pre-clinical and early development stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horton Valve Company.